Finance News – Cancer Drugs
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Investors
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Bse
Etf
Earnings
Stablecoin
Ipo
Investment
Blockchain
Index
Revenue
Solana
Trade
Sec
Interest Rates
Inflation
Token
Sensex
Wall Street
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Nse
Profit
Bse Sensex
China
Nifty
Sp 500
Gold
Investor
Tesla
Company
Defi
Gmx
Education
Options Market
Energy Bill
Nse Sme
National Security Adviser
Uk Wage Levels
Investment Interest
Recruit Holdings
Earnings Forecast
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jul 29, 2025
AstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 Results
AstraZeneca's financial performance improved in the second quarter, driven by increased demand in the US market and strong sales of oncology medications, positively influencing its...
Read Full Article →
City A.M. • Jul 29, 2025
Astrazeneca: Demand for cancer drugs boosts pharmaceutical giant
AstraZeneca experienced an 11 percent increase in total revenue to $28 billion in the first half, largely due to strong sales growth in its cancer treatment and biopharmaceutical s...
Read Full Article →